Skip to main content
. 2017 Nov 17;2017(11):CD005067. doi: 10.1002/14651858.CD005067.pub4

Comparison 48.

Paromomycin 15% + 12% MBCL (twice daily for 28 d) versus vehicle (twice daily for 28 d)

Outcome or subgroup title No. of studies No. of participants Statistical method Effect size
1 Lesions cured 1 Risk Ratio (M‐H, Random, 95% CI) Totals not selected
2 Scarring 1 Risk Ratio (M‐H, Random, 95% CI) Totals not selected
3 Microbiological cure of skin lesions 1 Risk Ratio (M‐H, Random, 95% CI) Totals not selected